This next generation CAD system is designed to enhance the overall clinical performance with Senographe and Seno Advantage systems, specifically improving sensitivity to breast cancer imaging, enhancing usability and workflow as well as providing diagnostic support tools.
"In an effort to provide leading solutions for our customers, GE has selected iCAD as our development partner for digital mammography CAD solutions," said David Caumartin, general manager of global mammography for GE Healthcare.
"iCAD's currently available revision of Secondlook Digital works well with GE's complete line of Senographe FFDM systems and Seno Advantage Review Work Stations and will continue to be a key aspect to the company's platform in an effort to provide the best technology with outstanding clinical value to our customers."
SecondLook Digital offers radiologists CAD technology that is designed to distinguish cancers from other anomalies in the breast. In addition to workflow advantages, SecondLook Digital detects up to 72 per cent of actionable missed cancers an average of 15 months earlier and integrates seamlessly with DICOM systems to improve workflow.
"We are very pleased to expand our partnership with GE Healthcare to optimize SecondLook Digital with Senographe and SenoAdvantage," said Ken Ferry, President and CEO of iCAD. "By customizing iCAD's technology for GE's systems, currently used in leading radiology centers worldwide, we believe that we will increase the many benefits of this system for radiologists, and ultimately provide an even higher level of detection for women."
Browse
related articles
GE Healthcare announces Developmental Agreement with iCAD at Arab Health
- United Arab Emirates: Tuesday, January 29 - 2008 at 12:52
- PRESS RELEASE
iCAD, Inc. an industry-leading provider of Computer-Aided Detection (CAD) solutions and GE Healthcare, a manufacturer of Senographe Full-Field Digital Mammography (FFDM) systems, recently announced an agreement to develop a customized version of SecondLook Digital specific to GE's Senographe and Seno Advantage family of systems.
Related stories
Also consider reading:
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
Log in to request more information from GE Healthcare
Notes and media contacts
About GE Healthcare:GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a US$17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
For further information, please contact:
Heather McPhail / Adnan Abdel-Razzak
ASDA'A Public Relations
Exclusive Affiliate of Edelman PR Worldwide in Middle East and North Africa
Tel: (+971 4) 334 4550
About iCAD, Inc.
iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by almost one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit www.icadmed.com.
For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604
For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770
Posted by Lara Lynn Golden, News EditorTuesday, January 29 - 2008 at 12:52 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
It looks like you are using a Mac - check out our 
Web Feeds